Delivery Order SPE2DB20D1100-SPE2DB24FZ13B
Award Date 12/5/23
Potential Completion Date 12/6/23
Potential Value $9.4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of TREMFYA 100 MG/ML INJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and...
- This federal contract award is for the delivery of TREMFYA 100 MG/ML syringes to the Defense Logistics Agency (DLA), a defense agency. The $8,017.07 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 17, 2023, with a completion date of February 21, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC...
- This federal contract award is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that was awarded to the parent company, Cencora, Inc. (doing business as Amerisourcebergen). The contract has a total ceiling value of $9,781.89 and a completion date of...
- This federal contract award is for the delivery of TREMFYA 100 MG/ML INJECTORMG, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $22,937.61 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 17, 2023 with a completion date of August 18, 2023. The contract is a delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award is for the delivery of TREMFYA 100 MG/ML INJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $19,106.07, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
- This federal contract award is for the delivery of TREMFYA 100 MG/ML SYRINGEML to the Defense Logistics Agency (DLA). The $41,340.92 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on February 28, 2024, with a completion date of February 29, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $17,179.37 and has an ultimate completion date of March 7, 2024. The award was made on March 6, 2024, and there was no set-aside...
- This federal contract award is for the delivery of TREMFYA 100 MG/ML syringes, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution firm. The contract has a ceiling value of $38,513.66 and an ultimate completion date of September 19, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract was...
- This federal contract award, with a value of $11,495.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TREMFYA 100 MG/ML INJECTORML. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of October 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of TREMFYA 100 MG/ML INJECTOR medication. The contract has a ceiling value of $17,746.28 and an ultimate completion date of August 23, 2023. This is a delivery order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025....
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FZ13BDelivery Order
This federal contract award is for the delivery of TREMFYA 100 MG/ML INJECTORML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $9,392.49, was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 5/12/25, 9:55 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 12/5/23 |